By Professor David Lawson Morris

Journal articles

Masoumi moghaddam S; Amini A; Morris DL; Pourgholami MH, 2012, 'Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer', Cancer and Metastasis Reviews, 31, pp. 143 - 162, http://dx.doi.org/10.1007/s10555-011-9337-5

Chua TC; Pelz JO; Morris DL, 2012, 'Surgery for colorectal peritoneal carcinomatosis', Scandinavian Journal of Gastroenterology, 47, pp. 277 - 285, http://dx.doi.org/10.3109/00365521.2012.640825

Saxena A; Chua TC; Perera M; Chu F; Morris DL, 2012, 'Surgical resection of hepatic metastases from neuroendocrine neoplasms: A systematic review.', Surgical Oncology, 21, pp. e131 - e141, http://dx.doi.org/10.1016/j.suronc.2012.05.001

Bahrami F; Morris DL; Pourgholami MH, 2012, 'Tetracyclines: drugs with huge therapeutic potential', Mini-Reviews in Medicinal Chemistry, 12, pp. 44 - 52, http://www.benthamdirect.org/pages/content.php?MRMC/2012/00000012/00000001/0006N

Amini A; Masoumi moghaddam S; Morris DL; Pourgholami MH, 2012, 'The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis', Current Cancer Drug Targets, 12, pp. 23 - 43, http://www.benthamdirect.org/pages/content.php?CCDT/2012/00000012/00000001/0003U.SGM

Chua TC; Morris DL, 2012, 'Therapeutic potential of surgery for metastatic colorectal cancer', Scandinavian Journal of Gastroenterology, 47, pp. 258 - 268, http://dx.doi.org/10.3109/00365521.2012.640823

Ng KM; Chua TC; Saxena A; Zhao J; Chu F; Morris DL, 2012, 'Two decades of experience with hepatic cryotherapy for advanced colorectal metastases.', Annals of Surgical Oncology, 19, pp. 1276 - 1283, http://dx.doi.org/10.1245/s10434-011-2025-4

Esquivel J; Sticca R; Sugarbaker P; Levine E; Yan TD; Alexander R; Baratti D; Bartlett D; Barone R; Barrios P; Bieligk S; Bretcha-Boix P; Chang CK; Chu F; Chu Q; Daniel S; Debree E; Deraco M; Dominguez-Parra L; Elias D; Flynn R; Foster J; Garofalo A; Gilly FN; Glehen O; Gomez-Portilla A; Gonzalez-Bayon L; Gonzalez-Moreno S; Goodman M; Gushchin V; Hanna N; Hartmann J; Harrison L; Hoefer R; Kane J; Kecmanovic D; Kelley S; Kuhn J; Lamont J; Lange J; Li B; Loggie B; Mahteme H; Mann G; Martin R; Misih RA; Moran B; Morris D; Onate-Ocana L; Petrelli N; Philippe G; Pingpank J; Pitroff A; Piso P; Quinones M; Riley L; Rutstein L; Saha S; Alrawi S; Sardi A; Schneebaum S; Shen P; Shibata D; Spellman J; Stojadinovic A; Stewart J; Torres-Melero J; Tuttle T; Verwaal V; Villar J; Wilkinson N; Younan R; Zeh H; Zoetmulder F; Sebbag G, 2011, 'Erratum: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement (Annals of Surgical Oncology 14 (128-133)DOI: 10.1245/s10434-006-9185-7)', Annals of Surgical Oncology, 18, http://dx.doi.org/10.1245/s10434-007-9599-x

Gruenberger T; Morris DL, 2011, 'Staged Treatment of Bilobar Hepatic Metastases from Colorectal Cancer', , http://dx.doi.org/10.3109/110241502321116578

Chua TC; Morris DL, 2011, 'Reply to Radiofrequency ablation as an adjunct to systemic chemotherapy for colorectal pulmonary metastases', Cancer, 117, pp. 876 - 877, http://dx.doi.org/10.1002/cncr.25548

Saxena A; Chua TC; Morris DL, 2011, 'In reply: Pseudomyxoma peritonei: Debulk or maximal cytoreduction?', Annals of Surgical Oncology, 18, pp. 284 - 285, http://dx.doi.org/10.1245/s10434-010-1194-x

Saxena A; Chua TC; Morris DL, 2011, 'In Reply: Pseudomyxoma Peritonei: Debulk or Maximal Cytoreduction?', ANNALS OF SURGICAL ONCOLOGY, 18, pp. 284 - 285, http://dx.doi.org/10.1245/s10434-010-1194-x

Yan TD; Deraco M; Elias D; Glehen O; Levine E; Moran BJ; Morris DL; Chua TC; Piso P; Sugarbaker PH; PSOG , 2011, 'A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database', Cancer, 117, pp. 1855 - 1863, http://dx.doi.org/10.1002/cncr.25640

Kim Y; Pourgholami MH; Morris DL; Stenzel M, 2011, 'An optimized RGD-decorated micellar drug delivery system for albendazole for the treatment of ovarian cancer: From RAFT polymer synthesis to cellular uptake', Macromolecular Bioscience, 11, pp. 219 - 233, http://dx.doi.org/10.1002/mabi.201000293

Latif E; Chua TC; Morris DL, 2011, 'Damage control surgery for liver rupture following selective internal radiation therapy for unresectable colorectal liver metastases', Australian and New Zealand Journal of Surgery, 81, pp. 570 - 572, http://dx.doi.org/10.1111/j.1445-2197.2011.05805.x

Chua TC; Al-Zahrani A; Saxena A; Glenn DW; Liauw W; Zhao J; Morris DL, 2011, 'Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.', Annals of Surgical Oncology, 18, pp. 1582 - 1589, http://dx.doi.org/10.1245/s10434-010-1492-3

Chua TC; Liauw W; Saxena A; Al-Mohaimeed K; Fransi S; Zhao J; Morris DL, 2011, 'Evolution of locoregional treatment for peritoneal carcinomatosis: Single-center experience of 308 procedures of cytoreductive surgery and perioperative intraperitoneal chemotherapy', American Journal of Surgery, 201, pp. 149 - 156, http://dx.doi.org/10.1016/j.amjsurg.2010.02.012

Chua TC; Saxena A; Liauw W; Chu F; Morris DL, 2011, 'Hepatic resection for metastatic breast cancer: A systematic review', European Journal of Cancer, 47, pp. 2282 - 2290, http://dx.doi.org/10.1016/j.ejca.2011.06.024

Chua TC; Saxena A; Chu F; Butler P; Quinn RJ; Glenn DW; Morris DL, 2011, 'Hepatic resection with or without adjuvant iodine-131-lipiodol for hepatocellular carcinoma - A comparative analysis', International Journal of Clinical Oncology, 16, pp. 125 - 132, http://dx.doi.org/10.1007/s10147-010-0143-9

Saxena A; Chua TC; Chu F; Morris DL, 2011, 'Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival', American Journal of Surgery, 202, pp. 310 - 320, http://dx.doi.org/10.1016/j.amjsurg.2010.08.041

Saxena A; Chua TC; Morris DL, 2011, 'In Reply: Pseudomyxoma peritonei: Debulk or maximal cytoreduction?', Annals of Surgical Oncology, 18, pp. 284 - 285, http://dx.doi.org/10.1245/s1034-010-1194-x

Chua TC; Morris DL; Saxena A; Esquivel J; Liauw W; Doerfer J; Germer CT; Kerscher A; Pelz J, 2011, 'Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: A multicenter study', Annals of Surgical Oncology, 18, pp. 1560 - 1567, http://dx.doi.org/10.1245/s10434-010-1522-1

Chua TC; Chu F; Morris DL, 2011, 'Outcomes of Single-Centre Experience of Hepatic Resection and Cryoablation of Sarcoma Liver Metastases', American Journal of Clinical Oncology - Cancer Clinical Trials, 34, pp. 317 - 320, http://dx.doi.org/10.1097/COC.0b013e3181e1d078

Pillai K; Akhter J; Pourgholami MH; Morris DL, 2011, 'Peritoneal mesothelioma in a woman who has survived for seven years : A case report', Journal of Medical Case Reports, 5:36, pp. 1 - 4, http://dx.doi.org/10.1186/1752-1947-5-36

Chua TC; Saxena A; Chu F; Zhao J; Morris DL, 2011, 'Predictors of cure after hepatic resection of colorectal liver metastases: An analysis of actual 5- and 10- year survivors', Journal of Surgical Oncology, 103, pp. 796 - 800, http://dx.doi.org/10.1002/jso.21864

Saxena A; Chua TC; Sarkar A; Chu F; Liauw W; Zhao J; Morris DL, 2011, 'Progression and survival results after radical hepatic metastasectomy of indolent advanced neuroendocrine neoplasms (NENs) supports an aggressive surgical approach', Surgery, 149, pp. 209 - 220, http://dx.doi.org/10.1016/j.surg.2010.06.008

Chua TC; Bester L; Saxena A; Morris DL, 2011, 'Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases', Journal of Cancer Research and Clinical Oncology, 137, pp. 865 - 873, http://dx.doi.org/10.1007/s00432-010-0948-y

Morris DL; Chua TC, 2011, 'Reply - Refers to:Is Malignant Dedifferentiation for Mucinous Appendiceal Neoplasms a Valid Phenomenon or Merely Histopathologic Ambiguity?', Journal of the American College of Surgeons, 212, pp. 907 - 907, http://dx.doi.org/10.1016/j.jamcollsurg.2011.02.001

Chua TC; Al-Alem I; Saxena A; Liauw W; Morris DL, 2011, 'Surgical cytoreduction and survival in appendiceal cancer peritoneal carcinomatosis: An evaluation of 46 consecutive patients.', Annals of Surgical Oncology, 18, pp. 1540 - 1546, http://dx.doi.org/10.1245/s10434-011-1714-3

Saxena A; Chua TC; Morris DL, 2011, 'Surgical Management and Emerging Therapies to Prolong Survival in Metastatic Neuroendocrine Cancer', Annals of Surgical Oncology, 18, pp. s222 - s223, http://dx.doi.org/10.1245/s10434-010-1342-3

Chua TC; Crowe PJ; Morris DL, 2011, 'Trends in surgical oncology research in Australia during the period 1998-2009-a bibliometric review.', Journal of Surgical Oncology, 104, pp. 216 - 219, http://dx.doi.org/10.1002/jso.21942

Pourgholami MH; Morris DL; Stenzel M; Kim Y, 2011, 'Triggering the fast release of drugs from crosslinked micelles in an acidic environment', Journal of Materials Chemistry, 21, pp. 12777 - 12783, http://dx.doi.org/10.1039/c1jm11062d

Chua TC; Liauw W; Zhao J; Morris DL, 2011, 'Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate', Annals of Surgery, 253, pp. 769 - 773, http://dx.doi.org/10.1097/SLA.0b013e31820b4dba

Chua TC; Crowe PJ; Morris DL, 2011, 'Whither surgical oncology?', ANZ Journal of Surgery, 81, pp. 763 - 764, http://dx.doi.org/10.1111/j.1445-2197.2011.05875.x

Morris DL; Roberts AL; Witherden AS; Tarzi R; Barros P; Whittaker JC; Cook TH; Aitman TJ; Vyse TJ, 2010, 'Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus', European Journal of Human Genetics, 18, pp. 1027 - 1031, http://dx.doi.org/10.1038/ejhg.2010.56

Yan TD; Sugarbaker PH; Elias D; Glehen O; Levine EA; Moran BJ; Deraco M; Morris DL; Piso P, 2010, 'Reply to M. Markman', Journal of Clinical Oncology, 28, http://dx.doi.org/10.1200/JCO.2010.29.1138

Cao C; Yan TD; Morris DL; Bester L, 2010, 'Radioembolization with Yttrium-90 Microspheres for Pancreatic Cancer Liver Metastases: Results from a Pilot Study', Tumori Journal, 96, pp. 955 - 958, http://dx.doi.org/10.1700/548.6515

Saxena A; Yan TD; Morris DL, 2010, 'Critical assessment of preoperative and operative risk factors for complications after iterative peritonectomy procedures', European Journal of Surgical Oncology, 36, pp. 309 - 314, http://dx.doi.org/10.1016/j.ejso.2009.06.008

Pourgholami MH; Szwajcer M; Chin M; Liauw W; Seef J; Galettis P; Morris DL; Links M, 2010, 'Phase i clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer', Cancer Chemotherapy and Pharmacology, 65, pp. 597 - 605, http://dx.doi.org/10.1007/s00280-009-1157-8

Feehally J; Farrall M; Boland A; Gale DP; Gut I; Heath S; Kumar A; Peden JF; Maxwell PH; Morris DL; Padmanabhan S; Vyse TJ; Zawadzka A; Rees AJ; Lathrop M; Ratcliffe PJ, 2010, 'HLA has strongest association with IgA nephropathy in genome-wide analysis', Journal of the American Society of Nephrology, 21, pp. 1791 - 1797, http://dx.doi.org/10.1681/ASN.2010010076

Saxena A; Yan TD; Morris DL, 2010, 'A critical evaluation of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis', World Journal of Surgery, 34, pp. 70 - 78, http://dx.doi.org/10.1007/s00268-009-0206-0

Esquivel J; Chua TC; Stojadinovic A; Melero JT; Levine E; Gutman M; Howard R; Piso P; Nissan A; Gomez-Portilla A; Gonzalez-Bayon L; Gonzalez-Moreno S; Shen P; Stewart J; Sugarbaker PH; Barone R; Hoefer R; Morris DL; Sardi A; Sticca R, 2010, 'Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: A multi-institutional study', Journal of Surgical Oncology, 102, pp. 565 - 570, http://dx.doi.org/10.1002/jso.21601

Pourgholami MH; Khachigian LM; Fahmy R; Badar S; Wang L; Chu SW; Morris DL, 2010, 'Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis', Biochemical and Biophysical Research Communications, 397, pp. 729 - 734, http://dx.doi.org/10.1016/j.bbrc.2010.06.019

Saxena A; Chua TC; Sarkar A; Chu F; Morris DL, 2010, 'Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic reseciton of intrahepatic cholangiocarcinoma: A 19-year experience from an Established Australian Hepatobiliary Unit', Journal of Gastrointestinal Surgery, 14, pp. 1128 - 1138, http://dx.doi.org/10.1007/s11605-010-1203-1

Chua TC; Saxena A; Chu F; Liauw WS; Zhao J; Morris DL, 2010, 'Clinicopathological determinants of survival after hepatic resection of hepatocellular carcinoma in 97 patients - Experience from an Australian Hepatobiliary Unit', Journal of Gastrointestinal Surgery, 14, pp. 1370 - 1380, http://dx.doi.org/10.1007/s11605-010-1277-9

Saxena A; Yan TD; Morris DL, 2010, 'Critical assessment of preoperative and operative risk factors for complications after iterative peritonectomy procedures', European Journal of Surgical Oncology, 36, pp. 309 - 314, http://dx.doi.org/10.1016/j-ejso.2009.06.008

Saxena A; Yan TD; Chua TC; Morris DL, 2010, 'Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei', Annals of Surgical Oncology, 17, pp. 1291 - 1301, http://dx.doi.org/10.1245/s10434-009-0875-9

Zhao Y; Pourgholami MH; Morris DL; Collins JG; Day AI, 2010, 'Enhanced cytotoxicity of benzimidazole carbamate derivatives and solubilisation by encapsulation in cucurbit[n]uril', Organic and Biomolecular Chemistry, 8, pp. 3328 - 3337, http://dx.doi.org/10.1039/c003732j

Pelz J; Chua TC; Esquivel J; Stojadinovic A; Doerfer J; Morris DL; Maeder U; Germer CT; Kerscher A, 2010, 'Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin.', BMC Cancer, 10:689, pp. 1 - 12, http://dx.doi.org/10.1186/1471-2407-10-689

Chua TC; Martin S; Saxena A; Liauw WS; Yan TD; Zhao J; Lok I; Morris DL, 2010, 'Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (Peritonectomy) at the St George Hospital peritoneal surface malignancy program', Annals of Surgery, 251, pp. 323 - 329, http://dx.doi.org/10.1097/SLA.0b013e3181c9b53c

Back to profile page